3Q22 Financial Highlights

O C T O B E R 1 7 , 2 0 2 2

3Q22 Financial Highlights

Revenue

EPS

Reported

Excluding

Reported

Excluding

notable items

notable items

(a)

$0.39

(a)

$4,279mm $4,242mm

$1.21

Pre-tax income

Pre-tax margin

Reported

Excluding

Reported

Excluding

notable items

notable items

$630mm

(a)

15%

(a)

$1,307mm

31%

  • Revenue up 6% YoY, up 5%(a) excluding the impact of notable items
    • Fee revenue down 1% YoY
    • Net interest revenue up 44% YoY
  • Expense up 26% YoY, up 4%(a) excluding the impact of notable items
    • Recorded a $680mm non-cash goodwill impairment charge(c)
  • Provision for credit losses was a benefit of $30mm compared to a provision benefit of $45mm in 3Q21

Returns

Capital ratios

Average loans up 11% YoY and down 1% QoQ

Reported

Excluding

notable items

Average deposits down 10% YoY and down 7% QoQ

ROE: 3.5%

10.9%(a)

T1L: 5.4%(c)

(b)

(a)

CET1: 10.0%(c)

Returned $0.3bn to common shareholders in dividends

ROTCE: 7.5%

22.4%

  1. Represents a non-GAAP measure. See pages 14 and 15 in the Appendix for the corresponding reconciliation of the non-GAAP measures of revenue, revenue growth, expense growth, pre-tax income, earnings per share, pre-tax margin, ROE and ROTCE excluding notable items.
  2. Represents a non-GAAP measure. See page 17 in the Appendix for the corresponding reconciliation of the non-GAAP measure of ROTCE.
  • (c) Impairment of goodwill associated with the Investment Management reporting unit, which was driven by lower market values and a higher discount rate. This goodwill impairment represents a non-cash charge and did not affect BNY Mellon's liquidity position, tangible common equity or regulatory capital ratios.

3Q22 Financial Results

3Q22 vs.

$mm, except per share data or unless otherwise noted

3Q22

2Q22

3Q21

2Q22

3Q21

Fee revenue

$3,236

$3,339

$3,265

(3)%

(1)%

Investment and other revenue

117

91

129

N/M

N/M

Net interest revenue

926

824

641

12%

44%

Total revenue

$4,279

$4,254

$4,035

Down 1%(c)

1%

Up 4%(c)

6%

Provision for credit losses

(30)

47

(45)

N/M

N/M

excluding

excluding

notable

notable

Noninterest expense

3,679

3,112

2,918

items

18%

items

26%

Income before income taxes

$630

$1,095

$1,162

(42)%

(46)%

Net income applicable to common shareholders

$319

$835

$881

excluding

(62)%

excluding

(64)%

Up 5%(c)

Up 11%(c)

EPS

$0.39

$1.03

$1.04

notable

(62)%

notable

(63)%

items

items

Avg. common shares and equivalents outstanding (mm) - diluted

815

814

849

-

Operating leverage(a)

Excluding

N/M

notable items

15%

26%

29%

Pre-tax margin

31%(c)

ROE

10.9%(c)

3.5%

9.3%

8.8%

ROTCE(b)

22.4%(c)

7.5%

19.2%

16.8%

+115 bps(c)

excluding

notable

items

(4)%

N/M

Notable items impacting the quarter

Increase / (decrease)

Revenue

Expense

EPS

3Q22

37

714

$(0.81)

Impact of goodwill impairment, a disposal gain, severance expense and litigation reserves

2Q22

-

103

$(0.12)

Impact of higher litigation reserves

3Q21

9

73

$(0.05)

Impact of litigation reserves, gains on disposals and severance expense

  1. Note: See page 12 in the Appendix for corresponding footnotes.
  2. Represents a non-GAAP measure. See page 17 in the Appendix for the corresponding reconciliation of the non-GAAP measure of ROTCE.
  • (c) Represents a non-GAAP measure. See pages 14 and 15 in the Appendix for the corresponding reconciliation of the non-GAAP measures of expense growth, earnings per share, operating leverage, pre-tax margin, ROE and ROTCE excluding notable items.
    N/M - not meaningful.

Capital and Liquidity

3Q22

2Q22

3Q21

Consolidated regulatory capital ratios:(a)

Tier 1 leverage ratio

5.4%

5.2%

5.7%

Supplementary leverage ratio ("SLR")

6.3

6.2

7.0

Common Equity Tier 1 ratio - Advanced Approaches

10.1

10.0

11.8

Common Equity Tier 1 ratio - Standardized Approach

10.0

10.1

11.7

Consolidated regulatory liquidity ratios:

Liquidity coverage ratio ("LCR")

116%

111%

111%

Cash dividends per common share

$0.37

$0.34

$0.34

Common stock dividends ($mm)

$303

$279

$296

Common stock repurchases ($mm)

2

3

2,001

Book value per common share

$43.18

$44.73

$47.30

Tangible book value per common share(b)

21.55

22.02

24.88

Common shares outstanding (mm)

808

808

826

  • Note: See page 12 in the Appendix for corresponding footnotes.

Net Interest Revenue and Balance Sheet Trends

N e t I n t e r e s t R e v e n u e

( $ m m )

+44%

+12%

926

824

641

3Q22 vs.

$bn, avg.

3Q22

2Q22

3Q21

Deposits:

Noninterest-bearing

$85

(8)%

(1)%

Interest-bearing

204

(7)%

(13)%

Total deposits

$288

(7)%

(10)%

Interest-earning assets:

Cash and reverse repo

131

(10)%

(17)%

Loans

68

(1)%

11%

Investment securities:

HQLA

121

(2)%

(4)%

Non-HQLA

27

(3)%

(9)%

Total investment securities

$148

(2)%

(5)%

3Q21

2Q22

3Q22

  • Net interest revenue of $926mm up 12% QoQ, primarily reflects higher interest rates on interest-earning assets, partially offset by higher funding expense

Total interest-earning assets

$352

(5)%

(8)%

  • Avg. deposits of $288bn down 7% QoQ
  • Avg. interest-earning assets of $352bn down 5% QoQ

5

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

The Bank of New York Mellon Corporation published this content on 13 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 January 2023 11:49:11 UTC.